![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1365287-97-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | Emibetuzumab REF: TM-T76743CAS: 1365287-97-3 | SDS-PAGE:96.2%;SEC-HPLC:98.8% | 142,00 €~662,00 € | Mar 16 Jul 24 |
![]() | Emibetuzumab REF: 3D-CLA1359CAS: 1365287-97-3 | - - - | A consultar | Mié 24 Jul 24 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Emibetuzumab
CAS:1365287-97-3
Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.
Pureza:
SDS-PAGE:96.2%;SEC-HPLC:98.8%
Forma y color:
Solid
Ref: TM-T76743
1mg | 142,00 € | ||
5mg | 416,00 € | ||
10mg | 662,00 € |
Entrega estimada en Estados Unidos, el Martes 16 de Julio de 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 3D-CLA1359
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 24 de Julio de 2024